REGENTS OF THE UNIVERSITY OF CALIFORNIA 13D and 13G filings for RAPT Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2021-02-01 3:30 pm Sale | 2020-12-31 | 13G | RAPT Therapeutics, Inc. RAPT | REGENTS OF THE UNIVERSITY OF CALIFORNIA | 1,122,237 4.489% | -220,000 (-16.39%) | Filing |
2020-02-24 3:37 pm Purchase | 2019-12-31 | 13G | RAPT Therapeutics, Inc. RAPT | REGENTS OF THE UNIVERSITY OF CALIFORNIA | 1,342,237 1.000% | 1,342,237 (New Position) | Filing |